Stephens analyst Scott Fidel raised the firm’s price target on Tenet Healthcare to $122 from $95 and keeps an Equal Weight rating on the shares. Tenet’s portfolio transformation initiative “assumed the spotlight” in Q1, positioning the business towards a more capital efficient and profitable enterprise, the analyst tells investors in a post-earnings note.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on THC: